logo

Horizon Pharma Inc (HZNP)



Trade HZNP now with
  Date
  Headline
9/29/2022 8:09:44 AM Horizon Completes Enrollment Of TEPEZZA In Adults With Score Thyroid Eye Disease
9/14/2022 8:09:41 AM Horizon Therapeutics Presents MIRROR Trial Data Of KRYSTEXXA Injection With Methotrexate In Arthritis & Rheumatology
9/12/2022 8:09:30 AM Horizon Therapeutics : Phase 2 Trial Of Dazodalibep In Sjgren's Syndrome Meets Primary Endpoint
9/9/2022 8:06:13 AM Horizon Therapeutics To Repurchase Up To $500 Mln Of Ordinary Shares
8/29/2022 4:03:09 AM Horizon Therapeutics Plans To Expand Development And Manufacturing Facility In Waterford, Ireland
8/15/2022 8:04:31 AM Q32 Bio, Horizon Therapeutics Collaborate To Develop ADX-914 for Treatment Of Autoimmune Diseases
8/3/2022 7:09:40 AM Horizon Therapeutics Q2 EPS $0.26 Vs. $0.67 Last Year
7/8/2022 8:06:04 AM Horizon Therapeutics : FDA Approves KRYSTEXXA Injection Co-Administered With Methotrexate
6/15/2022 8:35:58 AM Horizon Therapeutics Submits Regulatory Filing For UPLIZNA In Brazil
5/31/2022 8:12:51 AM Horizon : Phase 3 N-MOmentum Study Shows Effectiveness Of UPLIZNA Among Neuromyelitis Optica Spectrum Disorder
5/17/2022 8:13:16 AM Horizon Says First Patient Enrolled In Phase 2 Trial Evaluating Daxdilimab For Treatment Of Alopecia Areata
5/4/2022 7:12:46 AM Horizon Therapeutics Q1 EPS $0.87 Vs. Loss/shr $0.55 Last Year